Extended Data Fig. 2: CONSORT Diagram.
From: Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
GC/GEJ, gastric/gastroesophageal junction cancer; PC, pancreatic cancer. * Data are from the first 37 patients who were treated with CT041 and completed at least 12 weeks of follow-up as of the data cutoff date, 08 April 2021.
